Balgrist News https://www.balgrist.ch/ en_EN balgrist.ch Sun, 04 Jun 2023 02:13:29 +0200 Sun, 04 Jun 2023 02:13:29 +0200 balgrist.ch news-658 Sat, 10 Jun 2023 09:35:00 +0200 Basic course regional anesthesia and vascular puncture https://www.balgrist.ch//en/events/congresses-and-cpd/basic-course-regional-anesthesia-and-vascular-puncture-658/ Basic course in ultrasound controlled regional anesthesia and vascular puncture in daily practice. Zurich Ultrasound Days Lengg

In this basic course, nationally and internationally renowned course instructors, speakers and tutors will provide you with the necessary knowledge and basic skills to safely and efficiently apply ultrasound controlled regional anesthesia and vascular puncture in the daily practice of anesthesiology. We are very pleased to invite you to the second basic course and hope to see you in Zurich on Saturday 10 June 2023.

Co-course leader

  • Prof. Dr. med. Urs Eichenberger, Head of the Department of Anesthesiology, Intensive Care Unit and Pain Therapy, Balgrist University Hospital, Zurich
  • Prof. Dr. med. Michael Ganter, Head of the Department of Anesthesiology and Intensive Care Medicine, Hirslanden Clinic, Zurich

Other speakers / tutors

  • Andrea Hänny-Johner, MD, Specialist in Anesthesiology, Hirslanden Klinik Permanence, Bern
  • David Lorenzana, MD, Team Leader Pain Therapy, Balgrist University Hospital, Zurich
  • Kerstin Löhr, M.D., Senior Consultant Anesthesiology, Schulthess Clinic, Zurich
  • Lorenzo Perniola, MD, Specialist in Anesthesiology, Hirslanden Clinic, Zurich
  • Pablo Pütz, MD, Specialist in Anesthesiology and Intensive Care Medicine, Hirslanden Clinic, Zurich
  • Markus Risch, MD, Senior Physician, Anesthesiology, Balgrist University Hospital, Zurich
  • Michael Sager, M.D., Specialist in Anesthesiology and Interventional Pain Management (SSIPM), Cantonal Hospital Baselland, Liestal
  • Yusmely Salazar, MD, Senior Consultant Anesthesiology, Schulthess Clinic, Zurich

Accreditation

  • Swiss Society for Ultrasound in Medicine (SGUM): 8 credits applied for.
    Basic course for the acquisition of component 10 of the SGUM POCUS certificate of competence
  • Swiss Society for Anaesthesiology and Perioperative Medicine (SSAPM): 8 credits applied for

Event location
Universitätsklinik Balgrist
Auditorium Christian Gerber und Kursräume
Forchstrasse 340, 8008 Zürich

Directions: www.balgrist.ch/anreise

Course language
German

Number of participants
Maximum four people per tutor and ultrasound machine.

Participation fee
CHF 450.–

Online registration

Contact
Universitätsklinik Balgrist
Claudia Gasser-Fideeler
Email
+41 44 386 38 32

]]>
2023 Fachpersonen
news-656 Tue, 18 Apr 2023 09:00:00 +0200 OR-X enters test operations https://www.balgrist.ch/https://or-x.ch/2023/04/18/or-x-enters-test-operations/ The OR-X translational research center has reached its next milestone: after only 15 months of construction, the infrastructure is ready for test operations. It has been handed over by the project management team to the users at Balgrist University Hospital. 2023 Aktuelles news-366 Thu, 27 Oct 2022 07:45:00 +0200 Obligation to wear masks in case of cold symptoms https://www.balgrist.ch//en/coronavirus/ We ask all persons with cold symptoms to protect others from infection. Thank you for wearing a hygiene mask throughout the hospital. 2022 Aktuelles news-528 Thu, 06 Oct 2022 10:55:00 +0200 Collaboration with AO Foundation https://www.balgrist.ch//en/about-us/media/collaboration-with-ao-foundation-528/ Balgrist University Hospital and the AO Foundation are entering into a collaboration to create synergies in the areas of research, innovation, and education. The common goal is to optimize patient care and treatment outcomes in musculoskeletal diseases and trauma. The collaboration includes two jointly supervised PhD projects that begin in 2023.

With this collaboration, Balgrist University Hospital in Zurich and Davos-based AO Foundation are strengthening preclinical, translational, and clinical research in musculoskeletal medicine. Together with the AO Research Institute, Davos (ARI), the development of innovative and novel treatment methods and implants is being advanced for the benefit of patients. Furthermore, the research projects have the potential to achieve additional advances in surgical education and training.

A complementary win-win situation for patients

AO Executive Director Research and Development and ARI Director Geoff Richards says: "ARI is a research institute with a fully focused multidisciplinary research team on one campus and one of the top in the world when it comes to disc degeneration and regeneration, infection, and musculoskeletal biomechanics – the topics of the joint PhDs. Similarly, Balgrist University Hospital and their research units are very strong in translational sciences. This collaboration is a win-win due to proximity and complement of knowledge within our areas."

Professor Mazda Farshad, MD, Medical Director of Balgrist University Hospital, says: "We focus on translational research. As a leading orthopedic university hospital with an integrated paraplegia center, our physician scientists identify the problems that remain unanswered for patients and answer them together with basic researchers and developers. This fits perfectly with the founding philosophy of the AO. The historically grown research and innovation focuses of Balgrist University Hospital and the AO complement each other, and, when combined, will make Switzerland the country with the highest impact on musculoskeletal medicine."

Two joint PhD projects in 2023

The collaboration has already begun and includes two jointly supervised PhD projects that start in 2023 focusing on research projects at ARI and Balgrist University Hospital. One of the projects is on functionalized annulus fibrosus repair patch to prevent post-surgical disc complication and the other is on patient-specific optimization of spinal fusions using validated computer simulations.

News AO-Foundation

AO Research Institute

For additional information please contact

via Franziska Ingold, Head of Corporate Communications, Balgrist University Hospital
+41 44 386 14 15
kommunikation@remove-this.balgrist.ch

via Olga Harrington, Head of Corporate Communications, AO Foundation
+41 79 834 57 42
communications@remove-this.aofoundation.org

]]>
2022 Aktuelles
news-501 Thu, 28 Jul 2022 11:40:15 +0200 Center of excellence for spine surgery https://www.balgrist.ch//en/about-us/media/center-of-excellence-for-spine-surgery-501/ Founded in 2017, the University Spine Center Zurich has been certified a "Surgical Spine Center of Excellence" by the spine society EuroSpine. The Spine Center is a cooperation of eight different disciplines and the interdisciplinary team consists of specialists who dedicate themselves daily to the treatment of patients with spine problems. We thank our patients for their trust, which is reflected in about 20,000 consultations and more than 1300 operations per year. The certificate as Center of Excellence for Spine Surgery expresses the high quality standards of the University Spine Center Zurich and confirms us on our way to provide the best possible treatment for patients.

Find out more:
www.balgrist.ch/spine

]]>
2022 Aktuelles
news-467 Tue, 17 May 2022 13:27:00 +0200 Federation to support 12 million franc project https://www.balgrist.ch//en/about-us/media/federation-to-support-12-million-franc-project-467/ The Swiss Innovation Agency (Innosuisse) is supporting the PROFICIENCY project with 6 million Swiss francs. The project constitutes a paradigm shift in education and training for surgeons. Innovative, simulator-supported practical training will replace advanced training in the operating room. State-of-the-art technological developments make it already possible to simulate many sur-gical procedures in a true-to-life manner. However, a large part of the surgical  education  still happens in the operating room and during patient treatment. The PROFICIENCY pro-ject will enable a critical paradigm shift: Future surgeons will be able to learn and improve their surgical skills through highly-realistic simulator-supported training – without compro-mising patient safety. PROFICIENCY is build upon two columns. On the one hand, a modular curriculum will be developed that will be accessible on a digital learning platform. On the other hand – and this is very important– cutting-edge digital technologies will be de-veloped to make surgicaltraining more realistic, immersive and effective. The Swiss Inno-vation Agency (Innosuisse) supports the project, which has a total volume of 12 million Swiss francs, with a total of 6 million Swiss francs over the next four years.

Prof. Dr. sc. Philipp Fürnstahl, principal investigator at Balgrist University Hospital, ex-plained the significance of «PROFICIENCY» for surgical training: «The use of artificial in-telligence and augmented reality heralds the dawn of a new era for highly specialized surgi-cal training. In just a few years, the first prototypes can be integrated into highly modern learning centers such as the OR-X at Balgrist University and made available to young sur-geons.»

Researchers and developers from Balgrist University Hospital and the Balgrist Campus have researched, developed and tested the surgical innovations behind «PROFICIENCY». These innovations stem from the SURGENT (Surgeon Enhancing Technologies) project and also forms the basis for the new, translational OR-X teaching and research center. The OR-X center is currently under construction and will be brought into operation at Balgrist University Hospital next year.

«PROFICIENCY» is a cooperation between Balgrist University Hospital, Zurich University, ETH Zurich, Cantonal Hospital of St. Gallen, the Centre hospitalier universitaire vaudois (CHUV), Zurich University of Applied Sciences (ZHAW) and the four companies VirtaMed AG, Microsoft Schweiz GmbH, ORamaVR S.A. and Atracsys LLC.


More Information
PROFICIENCY
Innosuisse

Contact for additional Information
Prof. Dr. sc. Philipp Fürnstahl, via Franziska Ingold, Head of Corporate Communications, Balgrist University Hospital
+41 44 386 14 15, kommunikation@remove-this.balgrist.ch

 

]]>
2022 Aktuelles
news-463 Mon, 09 May 2022 13:27:00 +0200 FAROS Integration Week https://www.balgrist.ch//en/about-us/media/faros-integration-week-463/ From May 9 to 13, the FAROS Integration Week took place at Balgrist. As the research and development work of this HORIZON-2020 project is done in parallel in different European partner facilities, integration weeks take place regularly. They serve to synchronize and test the sensors, functional models and controls. The international research collaboration aims to develop surgical robots that use a wide range of sensory perceptions to autonomously perform complex surgical tasks.
 

«FAROS» a consortium of four universities: KU Leuven in Belgium, which is coordinating the project and driving the work in non-visual sensing, Sorbonne University in France, with a strong role in robotics, King's College London in England, which will lead the development of artificial intelligence, and Balgrist University Hospital / University of Zurich, which will work clinically, experimentally and interdisciplinary to ridge robotics, computer science and clinical research. The project has received funding from the European Union’s Horizon 2020 research and innovation programme. «FAROS» started with a three-year term on January 1, 2021.

 

More Information

FAROS-Balgrist
FAROS-Website
 

]]>
2022 Aktuelles
news-389 Wed, 26 Jan 2022 16:51:00 +0100 Operating Room X: start of construction https://www.balgrist.ch//en/about-us/media/operating-room-x-green-light-for-the-start-of-construction-389/ Construction work starts today on the OR-X, the new Translational Center for Surgery at Balgrist University Hospital. The test phase for the OR-X will be launched in the first quarter of 2023. The OR-X (Operating Room X) at Balgrist University Hospital is a new, translational surgical research and teaching Center. The first construction phase will start on Wednesday 26 January 2022, which constitutes a milestone for this significant project at Balgrist University Hospital. The launch of the test phase is scheduled for the first quarter of 2023. The OR-X will create new opportunities for surgical research, development and teaching, based in Zurich but with national relevance. Researchers and developers will be able to develop and validate new technologies and innovations more efficiently. New technologies can therefore be used in clinical applications more quickly (translation). Future surgeons can learn and gather surgical experience in a realistic operating theater – without endangering patient safety.

Visit OR-X website


For further information, contact 
Prof. Dr. med. Mazda Farshad
Medical Director, Balgrist University Hospital

via Franziska Ingold
Head of Communications, Balgrist University Hospital
+41 44 386 14 15
Email

]]>
2022 Aktuelles
news-368 Fri, 01 Oct 2021 13:33:00 +0200 Surgery «Dropped Head Syndrom» https://www.balgrist.ch//en/about-us/media/surgery-dropped-head-syndrom-368/ Thanks to a cutting-edge new surgical technique, a patient with Dropped head syndrome was successfully treated without the necessity of me-tallic implants and fusion. The surgical technique was developed at the University Spine Center Zurich. Dropped head syndrome (DHS), also known as floppy head syndrome, is a rare condition with a broad differential diagnosis. DHS has a considerable impact on the health and qual-ity of life of affected individuals. The neck extensors are weakened to such an extent that patients are unable to hold the head erect. Until now, extensive fixation and fusion of the cervical and thoracic spine has been the only possible treatment for DHS.

Prof. Mazda Farshad, Surgeon in Chief and Director of the University Spine Center Zurich at Balgrist University Hospital, and his team have now developed a new surgical technique making it possible to treat DHS for the first time successfully without fusion. This tech-nique, known as «occipitopexy», supports the head by using ligaments attached to the spine. Today, eighteen months after surgery, the patient, a 68-year-old female, is not only still able to support and maintain a normal head position, but also perform head movement functionality. This represents a less radical and very promising treatment to relieve the pa-tients’ suffering without restricting their quality of life by spinal fusion.

For further information, contact
Prof. Dr. med. Mazda Farshad, Medical Director, Balgrist University Hospital

Via Franziska Ingold, Head of Communications, Balgrist University Hospital
+41 44 386 14 15 / E-Mail

]]>
2021 Aktuelles
news-331 Thu, 21 Jan 2021 09:59:41 +0100 FAROS is the new EU Horizon project https://www.balgrist.ch/https://www.balgrist.ch/en/research/research-units/research-orthopaedics/faros/ The FAROS project aims to develop the next generation of surgical robotics that that scan, hear, feel and act. The research project brings together leading European institutes. Aktuelles Balgrist News news-328 Fri, 11 Dec 2020 09:21:41 +0100 First holographically navigated spine surgery https://www.balgrist.ch//en/research/research-units/augmented-reality/ A team at Balgrist University Hospital successfully completed the first holographically navigated spine surgery. 2020 Aktuelles news-300 Wed, 26 Aug 2020 17:36:37 +0200 Balgrist researcher awarded the Schellenberg Research Prize 2020 https://www.balgrist.ch/https://www.irp.ch/irp-schellenberg-research-prize/ The IRP Schellenberg Research Prize 2020 is awarded to Professors Patrick Freund, Balgrist University Hospital, Switzerland, and Jonas Frisén, Karolinska Institute, Sweden. The award ceremony will take place on October 1st, 2020 in Basel. 2020 Aktuelles Balgrist News news-290 Thu, 25 Jun 2020 12:58:00 +0200 Augmented reality world premiere https://www.balgrist.ch//en/about-us/media/augmented-reality-world-premiere-290/ An interdisciplinary team is laying the foundations for a pioneering study with holographically navigated spine surgery. At Balgrist University Hospital, for some years a team of experts from the fields of research, engineering and surgery have been looking at the possibility of augmented reality (AR) to assist with operations on the spine. Imaging data on AR glasses should soon make orthopedic operations more efficient, precise, and safer for the patient. Balgrist University Hospital is laying the foundations for this with the first clinical study of its type in the world.

“A prominent milestone on the way towards orthopedics shaped by computer technology, with the goal of allowing fully digitalized treatment”, says Prof. Philipp Fürnstahl, Head of ROCS at Balgrist.

The study, which was approved by Swissmedic, is being carried out as part of Zurich University Medicine’s SURGENT (Surgeon Enhancing Technologies) Flagship Project. Together with their technology partner, Microsoft, Balgrist ROCS (Research in Orthopedic Computer Science) and Incremed, a university start-up supported by Balgrist Beteiligungs AG, are currently testing AR-based surgical navigation in orthopedics. “In orthopedics, augmented reality is the key to creating new standards for carrying out precise patient-specific surgery. Thanks to the cooperation between the Zurich University, the University hospitals and the ETH, Zurich is at the cutting edge globally,” says Prof. Dr. med. Mazda Farshad, Head of the Flagship Project and Chief Medical Officer of Balgrist University Hospital.


An important step for AR technology in the operating roomIn the first study of its type to be carried out anywhere in the world, complex surgical operations on the spine will be performed with or without holographic navigation, following a randomization procedure. The results of the initial phase are expected to be available in autumn 2020. A comparison of the groups should provide the basis for an important step towards bringing AR technology from the research laboratory into operating theatres across the world. Prof. Philipp Fürnstahl, Head of ROCS at Balgrist, sees it as “a prominent milestone on the way towards orthopedics shaped by computer technology, with the goal of allowing fully digitalized treatment.” And Marianne Janik, CEO of Microsoft Switzerland, adds “Cooperation with Balgrist University Hospital shows that augmented reality and artificial intelligence can already support and even enhance human abilities and expertise. We are proud that our technology meets the very high quality requirements and that we can contribute to this pioneering work.”
 

Benefits for patients
3D images of the affected anatomy are generated on the basis of CT scans and displayed directly in the surgical field during the operation. Surgeons can see the patient’s 3D anatomy using AR glasses. The AR navigation software guides each step of the operation. For example, it shows the exact placement of a screw at the correct site and the appropriate angle, and verifies the accuracy. In addition to the precise positioning of implant components, rod implants can be measured and thus individually dimensioned. This allows an enhancement of the surgeon’s perceptive senses.


For further information, contact
Franziska Ingold, Heas of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

]]>
2020 Aktuelles
news-286 Thu, 18 Jun 2020 09:32:24 +0200 MRI study shows bone changes in the knee https://www.balgrist.ch//en/about-us/media/mri-study-shows-bone-changes-in-the-knee-286/ A study with junior ski athletes has found that more than half of the junior skiers have "distal femoral cortical irregularity" (DFCI). The study is a joint research project of the Radiology and Sports Medicine departments of Balgrist University Hospital in Zurich, Switzerland. The researchers examined the knee joints of youth competitive alpine skiers for the presence of distal femoral cortical irregularities (DFCIs). These are typically found at the attachment site of tendons on the posterior aspect of the femoral bone. These changes were present in more than half of the athletes while significantly fewer subjects in the control group were affected. It is thus clear that these DFCIs are of mechanical origin.

«The successful research project is an example of the interdisciplinary research activities at Balgrist University Hospital.»

A DFCI is usually an incidental finding on an MRI scan of the knee and often does not cause any symptoms. However, in the past such findings were often misinterpreted as tumors. The results of the study, which was published in the renowned journal Radiology, will considerably facilitate the diagnostic evaluation of such “pseudo-lesions”. In future, follow-up investigations and invasive bone biopsies will no longer be necessary. The successful research project is an example of the interdisciplinary research activities at Balgrist University Hospital, where researchers identify clinical problems in patients and translate them into corresponding scientific questions.

Distal femoral cortical irregularity (DFCI) on Knee MRI: Increased prevalence in youth
competitive alpine skiers. Stern C, Galley J, Fröhlich S, Peterhans L, Spörri J, Sutter R.
Radiology, 2020. [Epub before print] doi:10.1148/radiol.2020192589

Link to the study
 

For further information, contact
PD Dr. med. Reto Sutter, Chief of Radiology
via Franziska Ingold, Heas of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

]]>
2020 Aktuelles
news-277 Fri, 17 Apr 2020 07:46:47 +0200 Neuer Stv. Medizinischer Spitaldirektor https://www.balgrist.ch//en/about-us/media/armin-curt-zum-stv-medizinischer-spitaldirektor-ernannt-277/ Die Universitätsklinik Balgrist hat Prof. Dr. med. Armin Curt, Chefarzt und Direktor Zentrum für Paraplegie, zum Stv. Medizinischen Spitaldirektor befördert. Prof. Dr. med. Armin Curt, Chefarzt und Direktor des Zentrums für Paraplegie, wird per 1. Mai 2020 zum Stv. Medizinischen Spitaldirektor befördert.

Seit elf Jahren ist Prof. Armin Curt Ordinarius für Paraplegiologie an der Universität Zürich und Chefarzt und Direktor des Zentrums für Paraplegie an der Universitätsklinik Balgrist. Er führt ausserdem die Forschergruppe für Paraplegie im Balgrist Campus. Das Team betreibt intensive Grundlagenforschung der Querschnittlähmung und des Rückenmarks. Curt misst der klinischen Forschung grosse Bedeutung zu und war massgeblich an den Forschungserfolgen seines Fachgebiets beteiligt. Gegenwärtig leitet er die europäische NISCI-Studie.

Nach dem Medizinstudium an der Universität Köln und der Ausbildung in Neurologie und klinischer Neurophysiologie begann er an der Universität Zürich seine Spezialisierung in der Versorgung und Rehabilitation von Rückenmarkverletzungen. Von 2005 bis 2008 war er ausserordentlicher Professor für Neurologie und SCI-Forschung an der University of British Columbia Vancouver, Kanada. Er ist Träger von zahlreichen nationalen und internationalen Stipendien, Ehrungen und Preisen. Seine primären Interessen sind translationale Forschung im menschlichen SCI, Neuro-Rehabilitation, klinische Neurophysiologie und Neuro-Imaging im menschlichen SCI.

Prof. Dr. med. Mazda Farshad: «Ich freue mich sehr, dass mit Prof. Dr. med. Armin Curt die Stellvertretung meiner Funktion als Medizinischer Direktor der Universitätsklinik Balgrist optimal sichergestellt ist. Die Zusammenarbeit mit ihm ist seit mehreren Jahren etabliert und im Rahmen des Universitären Wirbelsäulenzentrums Zürich noch weiter intensiviert worden.»

]]>
2020 Aktuelles
news-276 Tue, 14 Apr 2020 18:09:41 +0200 Neue Stellvertreter der Orthopädie-Direktion https://www.balgrist.ch//en/about-us/media/neue-stellvertreter-der-orthopaedie-direktion-276/ Die Universitätsklinik Balgrist hat zwei neue Stv. Direktoren Orthopädie: PD Dr. med. Patrick Zingg (Klinik) und Prof. Jess Snedeker (Forschung). PD Dr. med. Patrick Zingg und Prof. Jess Snedeker werden zu Stv. Direktoren Orthopädie befördert; Patrick Zingg für den klinischen Bereich, Jess Snedeker für den Bereich Forschung Orthopädie. Sie treten die Nachfolge des Anfang Jahr verstorbenen Prof. Dr. med. Dominik Meyer an.

PD Dr. med. Patrick Zingg ist seit 2017 Leiter Hüft- und Beckenchirurgie und seit bald 20 Jahren an der Universitätsklinik Balgrist. Seine Spezialisierungen sind die gelenkserhaltende Chirurgie bei Impingement und bei Dysplasie (Hüftarthroskopie, periacetabuläre Beckenosteotomie, femorale Umstellungsosteotomie), die Prothetik (künstlicher Gelenksersatz) und die Revisionsprothetik (Prothesen-Wechsel, Rekonstruktion von Knochendefekten und Muskelschäden).

Prof. Jess Snedeker ist der Chief Scientific Officer des Balgirst Campus und seit bald 15 Jahren Leiter der Orthopädischen Biomechanik-Forschung an der Universitätsklinik Balgrist. Das Labor für Orthopädische Biomechanik ist eine multidisziplinäre Forschungseinheit, die sich wissenschaftlichen Fragen rund um den Bewegungsapparat widmet. Prof. Snedeker ist Inhaber eines gemeinsamen Lehrstuhls an der Universität Zürich und der ETH Zürich.

Prof. Dr. med. Mazda Farshad: «Es freut mich, dass mit der Beförderung von PD Dr. Patrick Zingg und Prof. Jess Snedeker die Stellvertretung meiner Funktion als Direktor Orthopädie hervorragend aufgestellt ist.»

]]>
2020 Aktuelles
news-271 Tue, 07 Apr 2020 08:27:01 +0200 Neuer Chefarzt Handchirurgie https://www.balgrist.ch//en/about-us/media/neuer-chefarzt-handchirurgie-271/ Andreas Schweizer tritt die Nachfolge von Ladislav Nagy an und wird neuer Chefarzt der Handchirurgie. Prof. Dr. med. Ladislav Nagy ist es seit 2002 gelungen, an der Universitätsklinik Balgrist eine international renommierte Handchirurgie aufzubauen und laufend weiterzuentwickeln. Ausserdem hat er es verstanden, einen exzellenten Nachfolger aufzubauen. Im Hinblick auf seine bevorstehende Pensionierung ist es Professor Nagys Wunsch, die Führungsaufgaben jetzt abzugeben. Er selbst wird der Universitätsklinik Balgrist sowie den Patientinnen und Patienten als Senior Consultant weiterhin zur Verfügung stehen.

2007 stiess Prof. Dr. med. Andreas Schweizer zur Universitätsklinik Balgrist. Mit innovativen Ideen hat er beträchtlich dazu beigetragen, die Handchirurgie an der Universitätsklinik Balgrist klinisch und akademisch voranzutreiben. Er gilt in seinem Fach als internatio-naler Experte und wird mit seinem Team das gesamte Spektrum der orthopädischen Handchirurgie sowie der peripheren Nervenchirurgie abdecken können.

Prof. Dr. med. Mazda Farshad, medizinischer Spitaldirektor der Universitätsklinik Balgrist, zum Wechsel in der Handchirurgie: «Ich freue mich, dass wir die Nachfolge der Leitung unserer Handchirurgie derart gezielt angehen konnten. Durch die interne Lösung ist die kontinuierliche Weiterentwicklung gewährleistet.»

Kontakte für weitere Informationen
Via Franziska Ingold, Leiterin Kommunikation
Universitätsklinik Balgrist
+41 44 386 14 15
E-Mail

]]>
2020 Aktuelles
news-270 Fri, 03 Apr 2020 10:21:00 +0200 Gesichtsschutz aus dem 3D-Drucker https://www.balgrist.ch//en/about-us/media/schutzmasken-aus-dem-3d-drucker-270/ Masken und Brillen zum Schutz vor dem neuen Coronavirus sind weltweit Mangelware. Das Forscherteam ROCS entwickelt zusammen mit dem Balgrist Campus und Balgrist Tec eine Art «face shield» für das Spitalpersonal. Das Team Research in Orthopedic Computer Science (ROCS) hat sich in der aktuellen, durch das neue Coronavirus verursachten Pandemielage mit den 3D-Druck-Spezialisten der Universitätsklinik Balgrist, der Balgrist Campus AG und der Balgrist Tec AG zusammengetan. Das Team hat eine innovative Lösung zur Bekämpfung des drohenden
Mangels an Schutzmaterial für das ganze Gesicht entwickelt.

Mit den eigenen 3D-Druckern werden ab sofort eigene Gesichtsschutze hergestellt. Die 3D-gedruckten Masken sind sterilisierbar und mit einer austauschbaren, sich nicht beschlagenden Spezialfolie versehen. Die ersten dieser Masken werden bereits in der Universitätsklinik Balgrist getestet und verwendet. Mit dieser Eigeninitiative leisten wir am Balgrist einen kleinen Beitrag zum Schutz des Spitalpersonals, das im Moment aussergewöhnliche Leistungen erbringt.

Hochpräzise Operationen dank Computertechnologie
Das ROCS ist ein interdisziplinäres und ambitioniertes Team aus Forschern, Ingenieuren und Chirurgen. Sie haben sich zum Ziel gesetzt, die Behandlung von Erkrankungen des Bewegungsapparates durch den Einsatz von Computertechnologie stetig zu verbessern. Zur ROCS-Forschungsgruppe gehört auch das Zentrum 3D-Planung und 3D-Druck der Universitätsklinik Balgrist, das die Chirurgen für schwierige orthopädische Operationen beiziehen können. Mit Hilfe von Computersimulation, Augmented Reality und 3D-Druck erarbeiten sie eine individuell auf den Patienten zugeschnittene Lösung und die Operation kann hochpräzise durchgeführt werden.
 

Kontakte für weitere Informationen
Prof. Dr. med. Mazda Farshad, Universitätsklinik Balgrist
Prof. Dr. Philipp Fürnstahl, Universitätsklinik Balgrist

Via Franziska Ingold, Leiterin Kommunikation
Universitätsklinik Balgrist
+41 44 386 14 15
E-Mail

]]>
2020 Aktuelles
news-268 Thu, 26 Mar 2020 15:18:00 +0100 Universitätsklinik Balgrist eröffnet Intensivstation https://www.balgrist.ch//en/about-us/media/universitaetsklinik-balgrist-eroeffnet-intensivstation-268/ Die Universitätsklinik Balgrist kann ihre Intensivstation und den Aufwachraum früher als geplant eröffnen und schafft so zusätzliche IPS-Kapazitäten. Die Inbetriebnahme der neuen Infrastruktur erforderte in den Tagen vor der Eröffnung eine erhöhte personelle Besetzung. Nur dank des engagierten Einsatzes und der Flexibilität des Spitalpersonals konnte diese früher als geplant eröffnet werden. Die Sicherheit der Patientinnen und Patienten hat oberste Priorität – alle Geräte zur Überwachung auf der Intensivstation wollen getestet sein und einwandfrei funktionieren. 

Behandlung von komplexen orthopädischen und paraplegischen Fällen
Der Balgrist hat als Universitätsklinik einen universitären Versorgungsauftrag und führt nebst der hochspezialisierten Diagnostik auch die Behandlung von komplexen Fällen in den Fachbereichen Orthopädie und Paraplegie durch. Mit der neuen Intensivstation und des Aufwachraums stellen wir sicher, dass die Versorgung von komplexen Behandlungen und seltenen Erkrankungen weiterhin gewährleistet ist.

  • Prof. Mazda Farshad, medizinischer Spitaldirektor: «Die Intensivstation ermöglicht die Behandlung aller orthopädischen Patienten, auch wenn es mal sehr kompliziert wird. Das differenziert die Universitätsklinik Balgrist als orthopädische Spezialklinik und erlaubt ihr die Tertiärversorgung.»

Auf der Intensivstation werden komplexe orthopädische Patientinnen und Patienten postoperativ intensivmedizinisch überwacht und gepflegt. Bei querschnittgelähmten Patienten stehen die Stabilisierung der lebenswichtigen Funktionen, die Prävention und Behandlung von Komplikationen, die Beatmung sowie die Schmerz- und Atemtherapie im Vordergrund.

Aktuell würden positiv auf das Coronavirus getestete Patienten isoliert und somit getrennt von orthopädischen oder paraplegischen Patienten behandelt. Damit kann die Universitätsklinik Balgrist das Gesundheitssystem tatkräftig unterstützen und mithelfen, den Ansturm auf die Akutspitäler zu entlasten.

Kontakt und Informationen
Kommunikation
+41 44 386 15 15
E-Mail

]]>
2020 Aktuelles
news-266 Mon, 16 Mar 2020 14:54:35 +0100 Virtual consultation as a supplementary service https://www.balgrist.ch//en/about-us/media/virtual-consultation-266/ In view of the current position regarding the coronavirus, Balgrist University Hospital is offering virtual consultations as a supplementary service for outpatients. As a University Hospital, we accept our responsibility for implementing the instructions of Switzerland’s Federal Office of Public Health (FOPH) and the Health Department of the Canton of Zurich, and protecting our patients to the best of our abilities.
 

Telephone and video consultations
From now on, outpatients can communicate directly with their doctor by phone or by video, as a supplement to their regular appointments. Of course, we offer this option as a priority to particularly vulnerable patient groups. This emergency measure allows us to make an important contribution to the safety of our patients.

Please do not hesitate to contact the relevant secretary’s office if you have any questions or need any assistance.

]]>
2020 Aktuelles
news-255 Sat, 01 Feb 2020 14:38:00 +0100 Professur für Orthopedic Computer Science https://www.balgrist.ch//en/about-us/media/neue-professur-fuer-orthopedic-computer-science-255/ Die Universität Zürich hat Prof. Dr. Philipp Fürnstahl per 1. Februar 2020 zum Professor für «Orthopädische Forschung mit Schwerpunkt Computer Science» ernannt. Prof. Dr. Philipp Fürnstahl ist einer Berufung durch die Universität Zürich gefolgt. Er übernimmt per 1. Februar 2020 einen Forschungs- und Lehrauftrag in orthopädischer Forschung mit Schwerpunkt Computer Science. Philipp Fürnstahl wird für die medizinische und naturwissenschaftliche Fakultät tätig sein und ist der Universitätsklinik Balgrist institutionell zugeordnet. Seine Forschung wird ein breites Spektrum von Gebieten der Informatik mit der Orthopädie vereinen, wie maschinelles Lernen, künstliche Intelligenz, Simulation und Augmentierte Realität, und die Translation in die Klinik sicherstellen. 


Prof. Philipp Fürnstahl

Prof. Dr. med. Mazda Farshad: «Die Professur «Computer Science in orthopedics» will in enger Zusammenarbeit mit den Ärzten die Behandlung der Patienten verbessern. Dafür werden neuste Computertechnologien erforscht, entwickelt und eingesetzt. Wir freuen uns auf die Ausweitung dieser bereits erfolgreichen Forschungsgruppe.»
 

ROCS - Research in Orthopedic Computer Science
An der Universitätsklinik Balgrist betreibt ein interdisziplinäres und ambitioniertes Team aus Forschenden, Ingenieurinnen, Ingenieuren, Chirurginnen und Chirurgen Forschung in computerassistierter, orthopädischer Chirurgie. Das Ziel ist, die Behandlungsmethoden von Krankheiten am Bewegungsapparat durch den Einsatz von Computertechnologie stetig zu verbessern.

Durch die Schaffung der neuen Professur wird das Forschungsteam um Philipp Fürnstahl breiter aufgestellt und neu strukturiert. ROCS – Research Orthopedic Computer Science. Der interdisziplinäre Charakter zeichnet dieses Forschungsteam aus mit Grundlagenforschern der Computer Science und Mediziner.  Neben der Forschung wird ein Teil des Teams in Form des «Zentrums für 3D-Operationsplanung und 3D-Druck» für die Patientenbehandlung tätig sein und die Chirurgie mit Computermethoden bei komplexen orthopädischen Operationen unterstützen.

]]>
2020 Aktuelles
news-219 Thu, 12 Sep 2019 10:00:00 +0200 Promising treatment for people with tetraplegia https://www.balgrist.ch//en/about-us/media/promising-treatment-for-people-with-tetraplegia-219/ A new therapy with antibodies gives reason for hope for patients with acute spinal cord injury. Recovery from acute spinal cord injury is unfortunately very limited and at present there are no medications available to treat the damaged spinal cord. Until now, rehabilitation has always been the most effective way of treating patients with spinal cord injuries. New medications with antibodies could be the breakthrough and allow the first real therapy for damaged nerves in the spinal cord.

 

For the first time, it seems possible to improve the recovery of nerve function using a medication that also helps patients recover considerably better. The new antibodies, an endogenous inhibitor,(Nogo-A protein), which prevents growth and regeneration of nerve fibres, can be blocked in humans. The treatment aims to improve the regeneration and plasticity of the nerve fibres so that they can reunite. This should considerably improve both the motor and sensory functions and the patient’s quality of life.

This antibody therapy is currently being tested in a clinical trial that is being conducted across Europe, which is looking at patients in the first few weeks of an accident causing tetraplegia. Prof. Armin Curt, Director of the Spinal Cord injury Centre at Balgrist University Hospital, is coordinating the project.

For further information please contact

Balgrist University
Communications

+41 44 386 14 15

]]>
2019 Aktuelles
news-213 Thu, 22 Aug 2019 13:48:34 +0200 Safer operations thanks to 3D operation planning https://www.balgrist.ch//en/about-us/media/safer-operations-thanks-to-3d-planning-and-surgical-navigation-213/ Balgrist University Hospital and Balgrist Campus complete their HSM2 project very successfully. In the project, clinical and campus have significantly advanced and further developed computer-assisted patient-specific 3D surgical planning. The methods enable novel surgical treatment options, provide greater patient safety, and improve outcome quality.

Focus on expansion of 3D planning methods

The new shoulder model developed by the researchers as part of the project, can be considered as one of the most comprehensive computer models for simulating patient-specific motions or bone and soft tissues pathologies. It includes three joints and 23 muscle components, including muscle fibres. In addition, the researchers were able to develop new methods for 3D planning and surgical navigation of tumour surgeries.

Great advances were also made in the surgical navigation of bone pathologies. Computer models combined with 3D printing allow highly accurate surgical planning tailored to the patient. The navigation system used is based on 3D-printed instruments that enable the surgeon to perform cutting and drilling highly accurate within millimeter accuracy. Clinical studies have shown that patients can be operated on more precisely, faster, and safer using these methods.

For further information please contact

Balgrist University Hospital 
Communications
+41 44 386 14 15

]]>
2019 Aktuelles